Bristol Puerto Rico Plant Cited By FDA; Firm Upgrades Out-Of-Spec Standards
Executive Summary
Bristol-Myers Squibb has updated standards for handling out-of-specification results at all of its pharmaceutical manufacturing facilities, the company told FDA in response to a recent warning letter issued after an inspection of its Mayaguez, Puerto Rico plant